MeSH term
Frequency | Condition_Probility | Humans | 33 | 0.0 |
Adolescent | 2 | 0.0 |
Animals | 12 | 0.0 |
Female | 4 | 0.0 |
Immunosuppressive Agents/*therapeutic use | 2 | 1.0 |
Male | 8 | 0.0 |
Rats | 6 | 0.0 |
Transplantation, Homologous | 2 | 0.0 |
Antibodies, Monoclonal/therapeutic use | 3 | 1.0 |
Recurrence | 3 | 0.0 |
CHO Cells | 3 | 0.0 |
Comparative Study | 3 | 0.0 |
Gene Expression | 2 | 0.0 |
Hamsters | 3 | 0.0 |
Mice | 3 | 0.0 |
Molecular Sequence Data | 8 | 0.0 |
Bone Marrow Transplantation | 2 | 0.0 |
Cytotoxicity, Immunologic | 5 | 0.0 |
Graft vs Host Disease/prevention & control | 2 | 3.0 |
In Vitro | 2 | 0.0 |
Lymphocyte Depletion | 3 | 1.0 |
T-Lymphocytes/immunology | 6 | 0.0 |
*Antigens, Neoplasm | 16 | 8.0 |
*Glycoproteins | 15 | 1.0 |
Research Support, Non-U.S. Gov't | 15 | 0.0 |
Adult | 4 | 0.0 |
Antigens, CD/immunology | 5 | 1.0 |
Bone Marrow Transplantation/*methods | 2 | 4.0 |
Graft Rejection | 2 | 1.0 |
Leukemia/*therapy | 2 | 1.0 |
Middle Aged | 2 | 0.0 |
Antigens, CD/*immunology | 2 | 0.0 |
Base Sequence | 5 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Dose-Response Relationship, Immunologic | 2 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
Antigens, CD/analysis | 3 | 0.0 |
Cell Line | 2 | 0.0 |
Interleukin-2/*pharmacology | 2 | 0.0 |
Bone Marrow Transplantation/*immunology | 2 | 1.0 |
Complement/immunology | 2 | 2.0 |
*Lymphocyte Depletion | 2 | 2.0 |
Flow Cytometry | 2 | 0.0 |
Reference Values | 2 | 0.0 |
Antibodies, Monoclonal/immunology/*therapeutic use | 2 | 6.0 |
Cell Adhesion Molecules/immunology | 3 | 4.0 |
Cell Adhesion | 2 | 0.0 |
T-Lymphocytes/*immunology | 2 | 0.0 |
Amino Acid Sequence | 6 | 0.0 |
*Antibodies, Monoclonal | 2 | 0.0 |
Antibodies, Monoclonal/immunology | 2 | 0.0 |
Complement/physiology | 2 | 4.0 |
Antigens, CD59 | 2 | 1.0 |
Lymphocytes/immunology | 2 | 0.0 |
Antigens, CD/*genetics | 2 | 0.0 |
Species Specificity | 2 | 0.0 |
